Charter Oak Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-192
Closed -$10K – 761
2022
Q2
$10K Buy
192
+82
+75% +$4.35K ﹤0.01% 599
2022
Q1
$6K Sell
110
-3
-3% -$155 ﹤0.01% 728
2021
Q4
$6K Sell
113
-441
-80% -$21.8K ﹤0.01% 682
2021
Q3
$27K Sell
554
-275
-33% -$14K ﹤0.01% 415
2021
Q2
$44K Hold
829
– – 0.01% 331
2021
Q1
$41K Hold
829
– – 0.01% 338
2020
Q4
$40K Buy
+829
New +$40.9K 0.01% 319

Other funds holding SNY

Charter Oak Capital Management's SNY Position: Q3 2022 in Review

Charter Oak Capital Management sold out of Sanofi (SNY) in Q3 2022, closing a stake of 192 shares — an estimated $10K sold.

Charter Oak Capital Management first reported a position in SNY in Q4 2020 and held it in 7 quarters. The position peaked at $44K in Q2 2021. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

  • Charter Oak Capital Management reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
  • Charter Oak Capital Management sold 192 Sanofi shares in Q3 2022, an estimated $10K.
  • Charter Oak Capital Management first reported a position in Sanofi in Q4 2020 and held it in 7 quarters.
  • Charter Oak Capital Management's Sanofi position peaked at $44K in Q2 2021.
  • 587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.